Literature DB >> 30933310

Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Yuan-Hao Chen1, Tsung-Hsun Hsieh2,3, Tung-Tai Kuo4, Jen-Hsin Kao1, Kuo-Hsing Ma5, Eagle Yi-Kung Huang6, Yu-Ching Chou7, Lars Olson8, Barry J Hoffer9,10.   

Abstract

To determine the role of reduced dopaminergic transmission for declines of forced versus spontaneous behavior, we used a model of Parkinson's disease with progressive degeneration of dopamine (DA) neurons, the MitoPark mouse. Mice were subjected to rotarod tests of motor coordination, and open field and cylinder tests for spontaneous locomotor activity and postural axial support. To measure DA release in dorsal striatum and the shell of Nucleus Accumbens (NAc), we used ex vivo fast-scan cyclic voltammetry in 6- to 24-week-old mice. To determine decline of DA transporter function, we used 18FE-PE2I positron emission tomography. We show here that fast-scan cyclic voltammetry is a sensitive tool to detect evoked DA release dysfunction in MitoPark mice and that electrically evoked DA release is affected earlier in nigrostriatal than mesolimbic DA systems. DA reuptake was also affected more slowly in NAc shell. Positron emission tomography data showed DA uptake to be barely above detection levels in 16- and 20-week-old MitoPark mice. Rotarod performance was not impaired until mice were 16 weeks old, when evoked DA release in striatum had decreased to ≈ 40% of wild-type levels. In contrast, impairment of open field locomotion and rearing began at 10 weeks, in parallel with the initial modest decline of evoked DA release. We conclude that forced behaviors, such as motivation not to fall, can be partially maintained even when DA release is severely compromised, whereas spontaneous behaviors are much more sensitive to impaired DA release, and that presumed secondary non-dopaminergic system alterations do not markedly counteract or aggravate effects of severe impairment of DA release. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  PET; Parkinson's disease; TFAM; dopamine; fast-scan cyclic voltammetry

Mesh:

Substances:

Year:  2019        PMID: 30933310      PMCID: PMC6592720          DOI: 10.1111/jnc.14702

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  33 in total

Review 1.  Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.

Authors:  O Hornykiewicz
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

Review 2.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

4.  Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry.

Authors:  E A Budygin; M R Kilpatrick; R R Gainetdinov; R M Wightman
Journal:  Neurosci Lett       Date:  2000-03-03       Impact factor: 3.046

5.  Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice.

Authors:  L Sörensen; M Ekstrand; J P Silva; E Lindqvist; B Xu; P Rustin; L Olson; N G Larsson
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 6.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

7.  Nicotine amplifies reward-related dopamine signals in striatum.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

8.  Frequency-dependent modulation of dopamine release by nicotine.

Authors:  Hui Zhang; David Sulzer
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

Review 9.  Nrf2 defends the lung from oxidative stress.

Authors:  Hye-Youn Cho; Sekhar P Reddy; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

10.  Kinetic analysis of striatal clearance of exogenous dopamine recorded by chronoamperometry in freely-moving rats.

Authors:  Jilla Sabeti; Cathy E Adams; Jason Burmeister; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Neurosci Methods       Date:  2002-11-15       Impact factor: 2.390

View more
  5 in total

1.  Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.

Authors:  Vicki Wang; Tung-Tai Kuo; Eagle Yi-Kung Huang; Kuo-Hsing Ma; Yu-Ching Chou; Zhao-Yang Fu; Li-Wen Lai; Jin Jung; Hoi-Ii Choi; Doo-Sup Choi; Yazhou Li; Lars Olson; Nigel H Greig; Barry J Hoffer; Yuan-Hao Chen
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-16

Review 2.  Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.

Authors:  Michael J Beckstead; Rebecca D Howell
Journal:  Exp Neurol       Date:  2021-03-20       Impact factor: 5.620

3.  Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice.

Authors:  Jaime M Ross; Giuseppe Coppotelli; Rui M Branca; Kyung M Kim; Janne Lehtiö; David A Sinclair; Lars Olson
Journal:  Aging Cell       Date:  2019-09-06       Impact factor: 9.304

Review 4.  Dopamine, behavior, and addiction.

Authors:  Roy A Wise; Chloe J Jordan
Journal:  J Biomed Sci       Date:  2021-12-02       Impact factor: 8.410

5.  Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice.

Authors:  Yuan-Hao Chen; Vicki Wang; Eagle Yi-Kung Huang; Yu-Ching Chou; Tung-Tai Kuo; Lars Olson; Barry J Hoffer
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.